EDGAR Filing Documents for 0001319244-09-000043

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0001319244-09-000043

Filing Date

2009-04-13

Accepted

2009-04-13 17:16:31

Documents

Group Members

CATAPULT CAPITAL MANAGEMENT LLCCATAPULT PARTNERS, LTD.ISRAEL A. ENGLANDERMILLENCO LLCMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq	Description	Document	Type	Size
1		acor_sc13d.htm	SC 13D	10579550
	Complete submission text file	0001319244-09-000043.txt		10581796

Mailing Address

Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300

ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81801 | Film No.: 09747100
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103

Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100

INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D